News
The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.
The retail giant has purchased CareZone's tech platform, patents and IP.
The system is able to continuously transmit glucose data every minute.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.
New funding will develop key markets and launch the company’s US presence.
The funding will be used to radically overhaul Germany’s desk-based operating health systems.
This brings the round's total equity raise to $100.7 million.
The company also announced its plans to launch Lumify, a handheld ultrasound device, in Japan.